About Shanghai Doning Biotechnology
Shanghai Doning Biotechnology is a Healthcare company based in Shanghai (China) founded in 2005. Serum-free cell culture media is supplied to biopharmaceutical industries. Shanghai Doning Biotechnology has raised $14.88 million across 3 funding rounds from investors including GL Capital, HongShan and Ally Bridge Group. Shanghai Doning Biotechnology has completed 1 acquisition, including PreFluid. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents.
Company details
Shanghai Doning Biotechnology was founded in 2005 in Shanghai, China. Serum-free cell culture media is provided by the company to biopharmaceutical sectors. Operations focus on products such as basic medium, feed medium, cell therapy medium, and one-time solutions. Services encompass personalized media development, cell culture process optimization, and commissioned formula production for customers.
- Headquarters Shanghai, China
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website duoningbio.com
- Social YouTube
- Total Equity Funding$14.88M (USD)
in 3 rounds
- InvestorsGL Capital
& 2 more
- Investments & Acquisitions
Apps and channels of Shanghai Doning Biotechnology
its YouTube channel Duoning has 25 subscribers and 18 videos.
Videos from Shanghai Doning Biotechnology
The most watched videos on Shanghai Doning Biotechnology's YouTube channel, Duoning (25 subscribers). Click a video to play it here.
More on Duoning.
Funding Insights of Shanghai Doning Biotechnology
Shanghai Doning Biotechnology has successfully raised a total of $14.88M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.88M
- Total Rounds 3
- Investors Count 3
All 3 funding rounds of Shanghai Doning Biotechnology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2021 | Series C | – | Gl-investment, HongShan | – | |
| Apr 2019 | $14.88M | Series A | – | Ally Bridge Group | – |
| Sep 2018 | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in Shanghai Doning Biotechnology
Shanghai Doning Biotechnology has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include GL Capital, HongShan and Ally Bridge Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and hedge fund investments in healthcare are managed. | ally-bridge.com | Hong Kong, China | ||
GL Capital is focused on healthcare sector value investments. | gl-investment.com | Beijing, China | ||
HongShan is engaged in venture capital investments for innovative companies. | hongshan.com | Hong Kong, China |
Investor details for Shanghai Doning Biotechnology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Shanghai Doning Biotechnology
1 people are tracked at Shanghai Doning Biotechnology (1 in team).
| Name | Role | Group |
|---|---|---|
Nicolas | PSS | Team |
Complete people profiles for Shanghai Doning Biotechnology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Shanghai Doning Biotechnology
Shanghai Doning Biotechnology has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include PreFluid.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Peristaltic pump solutions are supplied to pharmaceutical and chemical sectors. | prefluid.com | Changzhou, China | 2007 | Jul 2023 | •••• |
Complete acquisition details for Shanghai Doning Biotechnology
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Shanghai Doning Biotechnology
4 dated milestones of Shanghai Doning Biotechnology across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Shanghai Doning Biotechnology is founded.
- Funding First funding round.
- Funding Latest funding round, Series C,.
- Acquisition Acquires PreFluid.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Shanghai Doning Biotechnology
Complete news archive for Shanghai Doning Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shanghai Doning Biotechnology
Shanghai Doning Biotechnology was founded in 2005 and raised its 1st funding round 13 years after it was founded.
Shanghai Doning Biotechnology is headquartered in Shanghai, China.
Shanghai Doning Biotechnology is a funded company, having raised a total of $14.88M across 3 funding rounds to date.
Shanghai Doning Biotechnology was founded in 2005 in Shanghai, China. Serum-free cell culture media is provided by the company to biopharmaceutical sectors. Operations focus on products such as basic medium, feed medium, cell therapy medium, and one-time solutions. Services encompass personalized media development, cell culture process optimization, and commissioned formula production for customers.
Shanghai Doning Biotechnology has made 1 acquisition, including PreFluid.
Shanghai Doning Biotechnology has 3 investors. Key investors include GL Capital, HongShan, and Ally Bridge Group.